Abstract
Vaccines against HIV most likely need to elicit broadly neutralizing antibodies. In this issue of Immunity, Poignard and colleagues describe the co-evolution of a broadly neutralizing antibody and the virus that triggered it, providing a template for HIV vaccine design.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have